Advertisement
FREE ACCESS
Editors' ChoiceCARDIOLOGY

The lymphatic border patrol outwits inflammatory cells in myocardial infarction

Science Translational Medicine25 Jul 2018Vol 10, Issue 451DOI: 10.1126/scitranslmed.aau7379

Abstract

Lymphangiogenesis modulates inflammation by clearing immune cells in the infarcted heart in a lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1)–dependent process to ameliorate cardiac dysfunction.
The lymphatic vascular network plays a fundamental role in cardiac fluid regulation: It collects and drains lymph to mediastinal lymph nodes, preventing accumulation of leukocytes, macromolecules, and excessive interstitial fluid. The exact role of the lymphatic system in cardiac injury has not been fully established.
Using ligation of the left anterior descending coronary artery to obtain myocardial infarction (MI) in mice, Vieira and collaborators elegantly demonstrated that stimulation of the growth of lymphatic vessels—a process known as lymphangiogenesis—markedly improved myocardial function after cardiac ischemia. Lymphangiogenesis induced an active clearance of immune cells within the injured heart, eventually leading to the resolution of the inflammatory response, thereby reducing cardiac fibrosis and pathological remodeling. Mechanistically, the lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1), a protein essential in leukocyte docking, was identified as a key player in these processes. Lyve1 knock-out mice exhibited lower clearance of immune cells after MI compared with wild-type littermates; moreover, Lyve1 ablation triggered a progressive deterioration of myocardial function, accompanied by collagen deposition and scarring, in absence of any lymphatic vessel defects at baseline.
These findings elucidate the functional role of the cardiac lymphatic system after MI. Although the study mainly focused on the regulation of the innate immune response, it is possible that lymphangiogenesis could also regulate the programming of naïve T cells and macrophage polarization. These preclinical results have translational potential, providing the basis for novel therapeutic strategies aimed at enhancing lymphangiogenesis in patients with ischemic heart disease.

Highlighted Article

J. M. Vieira, S. Norman, C. Villa del Campo, T. J. Cahill, D. N. Barnette, M. Gunadasa-Rohling, L. A. Johnson, D. R. Greaves, C. A. Carr, D. G. Jackson, P. R. Riley, The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction. J. Clin. Invest. 10.1172/JCI97192 (2018).

Information & Authors

Information

Published In

Science Translational Medicine
Volume 10Issue 45125 July 2018

Permissions

Request permissions for this article.

Authors

Affiliations

Gaetano Santulli
Department of Medicine, Albert Einstein College of Medicine, Montefiore University Hospital, New York, NY 10461, USA; Department of Advanced Biomedical Sciences, “Federico II” University, Naples, 80131, Italy. Email: [email protected]

Metrics & Citations

Metrics

Citations

View Options

Media

Figures

Other

Tables

Share

Information & Authors
Published In
issue cover image
Science Translational Medicine
Volume 10|Issue 451
July 2018
Submission history
Metrics & Citations
Article Usage
Altmetrics
Export citation

Select the format you want to export the citation of this publication.

Share
Share article link

Share on social media
Get Access
Log in to view the full text

AAAS Log in

AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions, as well as limited access for those who register for access.

Log in via OpenAthens.
Log in via Shibboleth.
More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

View Options
Tables
References

(0)eLetters

No eLetters have been published for this article yet.

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.